Literature DB >> 18782140

Drug-induced long QT syndrome and drug development.

J M Ritter.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18782140      PMCID： PMC2526246          DOI： 10.1111/j.1365-2125.2008.03275.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  15 in total

1.  George Ralph Mines, ventricular fibrillation and the discovery of the vulnerable period.

Authors:  R A DeSilva
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

2.  Effect of atorvastatin on hs-CRP in acute coronary syndrome.

Authors:  Ankur Gupta; Dinesh K Badyal; Prem P Khosla; Bharti Uppal; Thannikot M Jaison; Sandeep Chopra
Journal:  Br J Clin Pharmacol       Date:  2008-07-15       Impact factor: 4.335

Review 3.  Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.

Authors:  D M Roden; R Lazzara; M Rosen; P J Schwartz; J Towbin; G M Vincent
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

4.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

5.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

6.  Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

Authors:  Ruth Dixon; Sarah Job; Ruth Oliver; Debra Tompson; John G Wright; Kay Maltby; Ulrike Lorch; Jorg Taubel
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

7.  Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failure.

Authors:  Satofumi Iida; Haruki Kinoshita; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2008-09       Impact factor: 4.335

Review 8.  The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.

Authors:  Giuseppina Novo; Daniela Guttilla; Giovanni Fazio; Debbie Cooper; Salvatore Novo
Journal:  Br J Clin Pharmacol       Date:  2008-09       Impact factor: 4.335

9.  The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters.

Authors:  Hossein Z Mirdamadi; Ferenc Sztanek; Zoltan Derdak; Ildiko Seres; Mariann Harangi; György Paragh
Journal:  Br J Clin Pharmacol       Date:  2008-09       Impact factor: 4.335

10.  Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France.

Authors:  Mariam Molokhia; Atul Pathak; Maryse Lapeyre-Mestre; Laetitia Caturla; Jean Louis Montastruc; Paul McKeigue
Journal:  Br J Clin Pharmacol       Date:  2008-07-15       Impact factor: 4.335
View more
  6 in total

1.  Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

2.  Novel targets and regulatory ordeal by QT interval.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

Review 3.  Assessing QT interval prolongation and its associated risks with antipsychotics.

Authors:  Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

4.  The role of concentration--effect relationships in the QTc interval prolongation: case sotalol.

Authors:  Pertti J Neuvonen; Erkki Elonen
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 5.  Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.

Authors:  Andrea C Tricco; Charlene Soobiah; Wing Hui; Jesmin Antony; Vladi Struchkov; Brian Hutton; Brenda Hemmelgarn; David Moher; Sharon E Straus
Journal:  BMC Pharmacol Toxicol       Date:  2015-01-26       Impact factor: 2.483

6.  Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis.

Authors:  Andrea C Tricco; Charlene Soobiah; Jesmin Antony; Brenda Hemmelgarn; David Moher; Brian Hutton; Sharon E Straus
Journal:  Syst Rev       Date:  2013-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.